Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Antibiotic Treatment of Moderate to Severe Bacterial Infections: Integration of PCR Technology and Medical Informatics/Artificial Intelligence

NCT01338116 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT01338116
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01338116 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Antibiotic Treatment of Moderate to Severe Bacterial Infections: Integration of PCR Technology and Medical Informatics/Artificial Intelligence
Lead sponsor
Rabin Medical Center
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2016
Completion date
May 13, 2019
Enrollment
600 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

community-associated infections, health-care acquired infections, nosocomial infections